Procanbid

Active Ingredient(s): Procainamide
FDA Approved: * January 31, 1996
Pharm Company: * KING PHARMS
Category: Irregular Heartbeat (Arrhythmia)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Procanbid Overview

Procainamide is a medication of the antiarrhythmic class used for the treatment of cardiac arrhythmias. It is classified by the Vaughan Williams classification system as class Ia; thus it is a sodium channel blocker of cardiomyocytes. In addition to blocking the INa current, it inhibits the IKr rectifier K+ current.[1] Procainamide is also known to induce a voltage-dependent open channel block on the batrachotoxin (BTX)-activated sodium channels in cardiomyocytes.[2&am...

Read more Procanbid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Procainamide

Recent Procanbid Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Procainamide
  • Capsule: 250mg, 375mg, 500mg
  • Injection: 100mg/ml, 500mg/ml
  • Tablet: 250mg, 375mg, 500mg
  • Tablet, Extended Release: 1000mg, 1gm, 250mg, 500mg, 750mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Procainamide or a similar ingredient: (1 result)

Related Procanbid Topics:

procanbid
I suffered severe physical damage from the aforementioned drug. Has anyone else had such an experience? There was nothin...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 September 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA